tradingkey.logo


tradingkey.logo


Tandem Diabetes Care Inc

TNDM
21.000USD
-2.320-9.95%
āļ›āļīāļ” 03/27, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
1.39BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
āļ‚āļēāļ”āļ—āļļāļ™P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Tandem Diabetes Care Inc āļšāļĢāļīāļĐāļąāļ—

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.

āļ‚āđ‰āļ­āļĄāļđāļĨ Tandem Diabetes Care Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™TNDM
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Tandem Diabetes Care Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļNov 13, 2013
āļ‹āļĩāļ­āļĩāđ‚āļ­Sheridan (John F)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™2650
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Nov 13
āļ—āļĩāđˆāļ­āļĒāļđāđˆ12400 High Bluff Drive
āđ€āļĄāļ·āļ­āļ‡SAN DIEGO
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX - NASDAQ BASIC
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ92130
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ18583666900
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.tandemdiabetes.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™TNDM
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļNov 13, 2013
āļ‹āļĩāļ­āļĩāđ‚āļ­Sheridan (John F)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Tandem Diabetes Care Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
124.69K
+5.69%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
51.27K
+3.44%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
42.63K
+4.03%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
37.66K
+4.47%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
28.36K
+15.47%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
25.27K
+4.04%
Mr. Jean-Claude (JC) Kyrillos
Mr. Jean-Claude (JC) Kyrillos
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
24.06K
+6.31%
Dr. Kathleen McGroddy-Goetz, Ph.D.
Dr. Kathleen McGroddy-Goetz, Ph.D.
Independent Director
Independent Director
17.85K
+24.57%
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Elizabeth A. Gasser
Ms. Elizabeth A. Gasser
Executive Vice President and Chief Strategy and Product Officer
Executive Vice President and Chief Strategy and Product Officer
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
124.69K
+5.69%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
51.27K
+3.44%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
42.63K
+4.03%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
37.66K
+4.47%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
28.36K
+15.47%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
25.27K
+4.04%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pump
110.11M
44.18%
Supplies and other - Domestic
90.85M
36.45%
Supplies and other-International
48.29M
19.38%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Domestic
84.78M
34.02%
International
25.33M
10.16%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pump
110.11M
44.18%
Supplies and other - Domestic
90.85M
36.45%
Supplies and other-International
48.29M
19.38%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
14.35%
The Vanguard Group, Inc.
10.72%
Sessa Capital
7.32%
ArrowMark Colorado Holdings, LLC
4.23%
GW&K Investment Management, LLC
3.92%
āļ­āļ·āđˆāļ™ āđ†
59.47%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
14.35%
The Vanguard Group, Inc.
10.72%
Sessa Capital
7.32%
ArrowMark Colorado Holdings, LLC
4.23%
GW&K Investment Management, LLC
3.92%
āļ­āļ·āđˆāļ™ āđ†
59.47%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
50.01%
Investment Advisor/Hedge Fund
30.77%
Hedge Fund
21.42%
Research Firm
8.46%
Pension Fund
1.22%
Bank and Trust
0.77%
Individual Investor
0.74%
Sovereign Wealth Fund
0.08%
Family Office
0.06%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
664
80.10M
118.13%
-22.02M
2025Q3
659
81.42M
120.08%
-12.14M
2025Q2
684
76.82M
113.72%
-10.68M
2025Q1
717
75.41M
113.22%
-13.00M
2024Q4
729
74.63M
112.27%
-13.07M
2024Q3
730
75.54M
115.38%
-14.87M
2024Q2
754
76.14M
117.84%
-16.88M
2024Q1
762
76.49M
116.55%
-10.19M
2023Q4
800
72.80M
111.65%
-12.99M
2023Q3
790
71.79M
110.32%
-10.32M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Institutional Trust Company, N.A.
10.15M
14.97%
+556.59K
+5.80%
Sep 30, 2025
The Vanguard Group, Inc.
7.05M
10.4%
-306.52K
-4.17%
Sep 30, 2025
Sessa Capital
5.00M
7.37%
--
--
Sep 30, 2025
ArrowMark Colorado Holdings, LLC
3.69M
5.44%
+991.65K
+36.73%
Sep 30, 2025
GW&K Investment Management, LLC
2.72M
4.01%
-168.48K
-5.83%
Sep 30, 2025
State Street Investment Management (US)
2.67M
3.94%
+22.30K
+0.84%
Sep 30, 2025
Two Sigma Investments, LP
2.09M
3.08%
-32.73K
-1.54%
Sep 30, 2025
Paradice Investment Management LLC
2.20M
3.24%
+429.29K
+24.29%
Sep 30, 2025
Jennison Associates LLC
1.42M
2.09%
-238.83K
-14.40%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
State Street SPDR S&P Health Care Equipment ETF
2.02%
Global X HealthTech ETF
1.14%
Invesco NASDAQ Future Gen 200 ETF
0.6%
Invesco S&P SmallCap Health Care ETF
0.58%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.38%
Inspire Small/Mid Cap ESG ETF
0.36%
Langar Global HealthTech ETF
0.35%
iShares S&P Small-Cap 600 Growth ETF
0.18%
Fidelity Enhanced Small Cap ETF
0.14%
State Street SPDR S&P 600 Small Cap Growth ETF
0.13%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
State Street SPDR S&P Health Care Equipment ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.02%
Global X HealthTech ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.14%
Invesco NASDAQ Future Gen 200 ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.6%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.58%
First Trust Nasdaq Lux Digi Health Solutions ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.38%
Inspire Small/Mid Cap ESG ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.36%
Langar Global HealthTech ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.35%
iShares S&P Small-Cap 600 Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.18%
Fidelity Enhanced Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.14%
State Street SPDR S&P 600 Small Cap Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.13%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™